Ilia I. Ouspenski

Array ( [id] => 9805239 [patent_doc_number] => 20150017185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'METHOD TO IMPROVE THE IMMUNE FUNCTION OF T CELLS' [patent_app_type] => utility [patent_app_number] => 14/361604 [patent_app_country] => US [patent_app_date] => 2012-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8591 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561726 [patent_doc_number] => 09624298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Anti-PD-L1 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/360775 [patent_app_country] => US [patent_app_date] => 2012-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 25684 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938913 [patent_doc_number] => 20140341933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 14/359764 [patent_app_country] => US [patent_app_date] => 2012-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19226 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905246 [patent_doc_number] => 20140308259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ISOLATED B7-H4 SPECIFIC COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/356040 [patent_app_country] => US [patent_app_date] => 2012-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34164 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607652 [patent_doc_number] => 08784815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Human CTLA-4 antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 13/666672 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 36 [patent_no_of_words] => 41198 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13666672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892544 [patent_doc_number] => 08916155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Method for the treatment of T cell mediated conditions by depletion of ICOS-positive cells in vivo' [patent_app_type] => utility [patent_app_number] => 13/657499 [patent_app_country] => US [patent_app_date] => 2012-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12359 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13657499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11656096 [patent_doc_number] => 09669078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'PD-L1 based immunotherapy' [patent_app_type] => utility [patent_app_number] => 14/352407 [patent_app_country] => US [patent_app_date] => 2012-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 10 [patent_no_of_words] => 25310 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9792234 [patent_doc_number] => 20150004178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'ANTI-HUMAN SEMA4A ANTIBODIES USEFUL TO TREAT DISEASE' [patent_app_type] => utility [patent_app_number] => 14/349836 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 20338 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8648841 [patent_doc_number] => 20130034571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'METHODS FOR INDUCING IN VIVO TOLERANCE' [patent_app_type] => utility [patent_app_number] => 13/645748 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9469 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13645748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9204952 [patent_doc_number] => 20140004129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Novel Polypeptides Involved in Immune Response' [patent_app_type] => utility [patent_app_number] => 13/633575 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 31452 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10134989 [patent_doc_number] => 09168296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Detection and treatment of autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 13/630364 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 14944 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732688 [patent_doc_number] => 20130078257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'USE OF AN ACTIVE SUBSTANCE BINDING TO CD28 FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF B-CLL' [patent_app_type] => utility [patent_app_number] => 13/625521 [patent_app_country] => US [patent_app_date] => 2012-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5438 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8720186 [patent_doc_number] => 20130071403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'SYNERGISTIC ANTI-TUMOR EFFICACY USING ALLOANTIGEN COMBINATION IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/622210 [patent_app_country] => US [patent_app_date] => 2012-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13862 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13622210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11678338 [patent_doc_number] => 09676855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'B7-H6 therapeutically active monoclonal antibody against B7-H6 polypeptide' [patent_app_type] => utility [patent_app_number] => 14/344499 [patent_app_country] => US [patent_app_date] => 2012-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 8172 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10162572 [patent_doc_number] => 09193789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune disease' [patent_app_type] => utility [patent_app_number] => 13/605468 [patent_app_country] => US [patent_app_date] => 2012-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 90150 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13605468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8744577 [patent_doc_number] => 20130084294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'ANTI-CD19 ANTIBODIES AND USES IN B CELL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/603154 [patent_app_country] => US [patent_app_date] => 2012-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 90347 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8820915 [patent_doc_number] => 20130121960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES' [patent_app_type] => utility [patent_app_number] => 13/595440 [patent_app_country] => US [patent_app_date] => 2012-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 17452 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953343 [patent_doc_number] => 20140356364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'Anti-B7-H4 Antibodies and Their Uses' [patent_app_type] => utility [patent_app_number] => 14/239117 [patent_app_country] => US [patent_app_date] => 2012-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 34192 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9641910 [patent_doc_number] => 20140220021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES COMPRISING PD-1 AGONIST' [patent_app_type] => utility [patent_app_number] => 14/237947 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15942 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9139803 [patent_doc_number] => 08580259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Human monoclonal antibodies to BTLA and methods of use' [patent_app_type] => utility [patent_app_number] => 13/553205 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 42 [patent_no_of_words] => 40224 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 526 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553205 [rel_patent_id] =>[rel_patent_doc_number] =>)